Impact of SARS CoV-2 pandemic on carbapenemase-producing Klebsiella pneumoniae prevention and control programme: convergent or divergent action?
Valeria Belvisi, Cosmo Del Borgo, Serena Vita, P. Redaelli, Pasquale Dolce, Daniela Pacella, Blerta Kertusha, Anna Carraro, R. Marocco, Margherita De Masi, Claudio Maria Mastroianni, Miriam Lichtner, Chiara Cosentino, L. Alibardi, L. De Marchis, Massimo Aiuti, Antonio Carraturo, Sergio Parrocchia, Alessandra Mecozzi, A. De Meo
Topics & Concepts
Klebsiella pneumoniaePandemicVirologyMicrobiologyCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Action (physics)2019-20 coronavirus outbreakMedicineBiologyEscherichia coliDiseaseInfectious disease (medical specialty)Internal medicineGeneGeneticsPhysicsOutbreakQuantum mechanicsAntibiotic Resistance in BacteriaAntibiotic Use and ResistanceBacterial Identification and Susceptibility Testing